CN110787322A - A kind of mineralized keratin biomimetic material and preparation method thereof - Google Patents
A kind of mineralized keratin biomimetic material and preparation method thereof Download PDFInfo
- Publication number
- CN110787322A CN110787322A CN201911131307.4A CN201911131307A CN110787322A CN 110787322 A CN110787322 A CN 110787322A CN 201911131307 A CN201911131307 A CN 201911131307A CN 110787322 A CN110787322 A CN 110787322A
- Authority
- CN
- China
- Prior art keywords
- keratin
- mineralized
- particles
- biomimetic material
- biomimetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000011782 Keratins Human genes 0.000 title claims abstract description 172
- 108010076876 Keratins Proteins 0.000 title claims abstract description 172
- 239000002977 biomimetic material Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000002245 particle Substances 0.000 claims abstract description 64
- 230000033558 biomineral tissue development Effects 0.000 claims abstract description 43
- 210000005258 dental pulp stem cell Anatomy 0.000 claims abstract description 33
- 230000012010 growth Effects 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 17
- 239000012890 simulated body fluid Substances 0.000 claims abstract description 14
- 230000035755 proliferation Effects 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 21
- 239000006228 supernatant Substances 0.000 claims description 7
- 238000005119 centrifugation Methods 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 238000009777 vacuum freeze-drying Methods 0.000 claims 1
- 230000003592 biomimetic effect Effects 0.000 abstract description 8
- 102000004169 proteins and genes Human genes 0.000 abstract description 8
- 108090000623 proteins and genes Proteins 0.000 abstract description 8
- 230000017423 tissue regeneration Effects 0.000 abstract description 8
- 229920002521 macromolecule Polymers 0.000 abstract description 7
- 238000001308 synthesis method Methods 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 21
- 238000012360 testing method Methods 0.000 description 20
- 238000004113 cell culture Methods 0.000 description 15
- 238000001514 detection method Methods 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 210000004262 dental pulp cavity Anatomy 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 230000004069 differentiation Effects 0.000 description 6
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 6
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- NQTSTBMCCAVWOS-UHFFFAOYSA-N 1-dimethoxyphosphoryl-3-phenoxypropan-2-one Chemical compound COP(=O)(OC)CC(=O)COC1=CC=CC=C1 NQTSTBMCCAVWOS-UHFFFAOYSA-N 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000000684 flow cytometry Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000000101 transmission high energy electron diffraction Methods 0.000 description 5
- 210000003074 dental pulp Anatomy 0.000 description 4
- 210000004268 dentin Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 239000008223 sterile water Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000018199 S phase Effects 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 210000004416 odontoblast Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009415 formwork Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000004626 scanning electron microscopy Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000003746 surface roughness Effects 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 1
- 230000035519 G0 Phase Effects 0.000 description 1
- 230000010190 G1 phase Effects 0.000 description 1
- 230000010337 G2 phase Effects 0.000 description 1
- 230000004668 G2/M phase Effects 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 230000027311 M phase Effects 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 206010062544 Tooth fracture Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000001053 ameloblast Anatomy 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 239000005312 bioglass Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000008619 cell matrix interaction Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 108010045512 cohesins Proteins 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 208000007147 dental pulp necrosis Diseases 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000010883 osseointegration Methods 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000013379 physicochemical characterization Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000012372 quality testing Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004098 selected area electron diffraction Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 210000001114 tooth apex Anatomy 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical group O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种矿化角蛋白仿生材料的制备方法,其包括如下操作步骤:1)纳米级角蛋白粉剂以0.1~500mg/ml的浓度加入无菌模拟体液环境中,静置矿化处理,后经收集、真空冷冻干燥、研磨成粉,得矿化角蛋白颗粒;2)矿化角蛋白颗粒以0.1~500mg/ml的浓度经重悬后注入模板中,后置于烘箱中干燥,得膜状的矿化角蛋白仿生材料。本发明通过仿生合成法,诱导角蛋白自行矿化,在无需引入其它蛋白因子或者其它生物大分子的前提下构建出矿化角蛋白仿生材料。经实践表明该仿生材料可为DPSCs的生长和增殖提供一个理想的纳米矿化微环境以促进DPSCs的生长,从而为牙髓组织再生与修复的可行性提供重要的参考价值。The invention discloses a preparation method of a mineralized keratin biomimetic material, which comprises the following operation steps: 1) adding nano-scale keratin powder at a concentration of 0.1-500 mg/ml into a sterile simulated body fluid environment, and allowing it to stand for mineralization treatment , and then collected, vacuum freeze-dried, and ground into powder to obtain mineralized keratin particles; 2) The mineralized keratin particles were resuspended at a concentration of 0.1-500 mg/ml and injected into the template, and then placed in an oven to dry, A film-like mineralized keratin biomimetic material was obtained. The invention induces the self-mineralization of keratin through the biomimetic synthesis method, and constructs the biomimetic material of mineralized keratin without introducing other protein factors or other biological macromolecules. Practice shows that the biomimetic material can provide an ideal nano-mineralized microenvironment for the growth and proliferation of DPSCs to promote the growth of DPSCs, thus providing an important reference value for the feasibility of pulp tissue regeneration and repair.
Description
技术领域technical field
本发明涉及生物医用材料,特别涉及一种矿化角蛋白仿生材料。The invention relates to biomedical materials, in particular to a mineralized keratin biomimetic material.
背景技术Background technique
牙髓炎症、牙髓坏死及各类牙髓疾病,是常见而高发的口腔疾病,疾病发生过程伴随的牙髓组织坏死和严重的炎症反应,将导致剧烈的疼痛,对患者的正常饮食和生活造成不利的影响。当前,这类疾病的治疗方法以根管充填为主,因病变已造成牙齿根管内部的组织和细胞的损伤,故治疗思路是在杀死或清除牙髓腔中正常和病变组织之后,采用材料或药物填充根管,以实现止痛、消炎和防止病变扩散的效果。充填根管的材料根据其物理性能可分为固体类、液体类和糊剂类三种,而其中,固体类充填剂又常以马来乳胶、金属银或聚丙烯为主体,这些材料在治疗过程中各有优缺点。但是,目前根管治疗方式的根本作用是采用无活性材料消灭根管和髓腔,消灭死腔,杜绝再次感染来源,并未修复牙髓,而牙髓的缺失将导致牙体硬组织得不到营养来源,从而脆性增加,牙体折裂的发生率较活髓牙明显增高。因此,未来日益完善的根管治疗方案应该是能够促进牙髓再生、构建健康牙齿的策略,也因此,寻找一种具有促进牙髓组织再生的材料是牙髓再生研究的热点与难点之一。Pulp inflammation, pulp necrosis and various kinds of pulp diseases are common and high-incidence oral diseases. The pulp tissue necrosis and severe inflammatory reaction accompanying the disease process will lead to severe pain, which is very important to the patient's normal diet and life. cause adverse effects. At present, root canal filling is the main treatment method for this type of disease. Because the disease has caused damage to the tissues and cells inside the root canal of the tooth, the treatment idea is to kill or remove the normal and diseased tissues in the pulp cavity. The root canal is filled with materials or drugs to relieve pain, reduce inflammation and prevent the spread of lesions. Materials for root canal filling can be divided into three types: solid, liquid and paste according to their physical properties. Among them, solid fillings are often dominated by Malay latex, metallic silver or polypropylene. These materials are used in treatment. There are pros and cons to each process. However, the fundamental role of the current root canal treatment is to use inactive materials to eliminate the root canal and pulp cavity, eliminate the dead space, eliminate the source of re-infection, and does not repair the pulp, and the loss of the pulp will lead to the loss of the hard tissue of the tooth. To the source of nutrition, the fragility increases, and the incidence of tooth fracture is significantly higher than that of living pulp teeth. Therefore, the increasingly perfect root canal treatment plan in the future should be a strategy that can promote pulp regeneration and build healthy teeth. Therefore, finding a material that can promote pulp tissue regeneration is one of the hot spots and difficulties in pulp regeneration research.
从组织结构层面来看,牙根管中的牙髓组织结构相对其它器官中的组织结构而言比较简单:牙根管呈中空,内含牙髓干细胞(dental pulp stem cells,DPSCs);DPSCs向外周分化,形成牙本质细胞和造釉细胞;末梢神经和血管通过牙根底部的根尖孔进入牙髓内部,对牙齿起滋养和调控的作用。当前研究表明,DPSCs所处的环境对其生长、增殖和分化都将产生影响。特别的,钙化外环境可能与牙髓中各种细胞,尤其是DPSCs,相互影响、相互调控。一方面,DPSCs的成骨化、成牙本质细胞化或成牙釉质细胞化将增加细胞外环境中的钙含量,而这种钙环境的最终形成是牙髓、牙釉质和牙本质修复的目的和保障;另一方面,钙离子环境提高了材料界面的生物活性和生物相容性,促进了DPSCs的增殖和分化,可以使后者数量明显增加:例如,Tu等研究发现,相比于空白组而言,用羟基磷灰石处理的DPSCs细胞活力更高;Chen等的研究表明,矿化的材料表面将提高DPSCs的骨整合能力,使其更好的与材料界面相融,生长出更紧密的细胞结构;Türkkan等发现,培养基中CaP浓度的增加将有助于DPSCs对材料的粘附和生长。From the perspective of tissue structure, the tissue structure of dental pulp in the root canal is relatively simple compared with the tissue structure in other organs: the root canal is hollow and contains dental pulp stem cells (DPSCs); Peripheral differentiation to form odontoblasts and ameloblasts; peripheral nerves and blood vessels enter the pulp through the apical foramen at the bottom of the root to nourish and regulate the tooth. Current studies have shown that the environment in which DPSCs live will affect their growth, proliferation, and differentiation. In particular, the external environment of calcification may interact and regulate each other with various cells in the dental pulp, especially DPSCs. On the one hand, the ossification, odontoblastization or odontoblastization of DPSCs will increase the calcium content in the extracellular environment, and the final formation of this calcium environment is the purpose of pulp, enamel and dentin repair On the other hand, the calcium ion environment improves the bioactivity and biocompatibility of the material interface, promotes the proliferation and differentiation of DPSCs, and can significantly increase the number of the latter: for example, Tu et al. found that compared with blank In terms of group, the cell viability of DPSCs treated with hydroxyapatite was higher; Chen et al.'s study showed that the mineralized surface of the material would improve the osseointegration ability of DPSCs, make it better integrate with the material interface, and grow more Tight cellular structure; Türkkan et al. found that an increase in the CaP concentration in the medium would facilitate the adhesion and growth of DPSCs to the material.
因此,能否为DPSCs创造一个理想的矿化微环境以促进其增殖和向牙本质细胞分化,是牙髓组织再生的一个关键。仿生学研究为寻找和构建这样的较理想的材料提供了思路,在模拟生物内环境的条件下构建材料,是当前生物材料领域研究的方法之一。值得一提的是,仿生法合成各类生物材料的最终目的绝不是单一地复制生物矿物,而是在认识自然界中生物矿化原理的基础上,指导人工矿化材料的合成,同时,通过改善材料的合成方式,最终创造出具有优越性能的各类无机材料。但是,矿化不能凭空产生,需要生物大分子作为支架和媒介,而现时并未获得理想的矿化微环境能有效、稳定地促进DPSCs增殖和向牙本质细胞分化。Therefore, whether to create an ideal mineralized microenvironment for DPSCs to promote their proliferation and differentiation into odontoblasts is a key to the regeneration of dental pulp tissue. Biomimicry research provides ideas for finding and constructing such ideal materials. Building materials under the conditions of simulating the internal environment of organisms is one of the current research methods in the field of biomaterials. It is worth mentioning that the ultimate purpose of biomimetic synthesis of various biological materials is by no means simply replicating biological minerals, but guiding the synthesis of artificial mineralized materials on the basis of understanding the principles of biomineralization in nature. The synthesis method of materials eventually creates various inorganic materials with superior properties. However, mineralization cannot be generated out of thin air and requires biological macromolecules as scaffolds and media, and currently there is no ideal mineralized microenvironment that can effectively and stably promote the proliferation and differentiation of DPSCs into odontoblasts.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于针对上述现有技术的不足,提供一种矿化角蛋白仿生材料的制备方法,其获得的矿化角蛋白仿生材料将为DPSCs的生长提供一个理想的纳米矿化微环境,以及调控DPSCs的生长与增殖,从而为牙髓组织再生获得新的填充材料。The object of the present invention is to provide a preparation method of a mineralized keratin biomimetic material for the deficiencies of the above-mentioned prior art, and the obtained mineralized keratin biomimetic material will provide an ideal nano-mineralization microenvironment for the growth of DPSCs, And regulate the growth and proliferation of DPSCs, so as to obtain new filling materials for pulp tissue regeneration.
本发明引入了仿生合成法(biomimetic synthesis),简而言之,就是模拟自然生物矿化的过程,在模拟体液中使生物大分子表面发生矿化累积、合成磷酸三钙、羟基磷灰石或类似结构。近年来,使用蛋白质、核酸等生物大分子作为模板的研究报道逐渐增加。例如,Xu等便采用这一方法构建矿化生物玻璃支架,促进骨细胞在其上的生长;Li等则利用左旋多巴胺上的酚羟基来诱导羟基磷灰石的生成,研制出与生物体内成分相仿的PDA复合粉体;Zhang等同样利用多巴胺作为模板,合成针型和微球型羟基磷灰石。The present invention introduces biomimetic synthesis, which, in short, simulates the process of natural biomineralization, makes the surface of biomacromolecules mineralize and accumulates in simulated body fluids, synthesize tricalcium phosphate, hydroxyapatite or similar structure. In recent years, research reports using biological macromolecules such as proteins and nucleic acids as templates have gradually increased. For example, Xu et al. used this method to construct a mineralized bioglass scaffold to promote the growth of bone cells on it; Li et al. used the phenolic hydroxyl group on L-dopamine to induce the formation of hydroxyapatite, and developed a biological component Similar PDA composite powder; Zhang et al. also used dopamine as a template to synthesize needle-type and microsphere-type hydroxyapatite.
但矿化是不能凭空产生的,需要生物大分子作为支架和媒介,而在生物大分子中,角蛋白(keratin)是一种理想的结构性材料。该蛋白分子单体成管状,两分子蛋白单体互相盘绕形成结构单元,并且结构单元平行排列,互相之间以氢键形成交联,在空间上呈现有序的结构。角蛋白因其坚韧的特性成为多种生物器官的主要成分,例如指甲、鸟喙或毛发。因此,角蛋白亦被视为构建仿生支架理想的材料之一。However, mineralization cannot be produced out of thin air, and requires biological macromolecules as scaffolds and media. Among biological macromolecules, keratin is an ideal structural material. The protein monomers are tubular, and two protein monomers are coiled with each other to form structural units, and the structural units are arranged in parallel, forming cross-links with each other by hydrogen bonds, showing an ordered structure in space. Because of its tough properties, keratin is the main component of many biological organs, such as nails, bird beaks or hair. Therefore, keratin is also regarded as one of the ideal materials for constructing biomimetic scaffolds.
由于半胱氨酸中游离巯基的存在和水溶性较低这两大特点,角蛋白具有力学结构可塑性和可改善性。因此,由角蛋白所构建的生物学结构常常具有增强的机械强度。此外,角蛋白还具有细胞结合基序,如亮氨酸-天冬氨酸-缬氨酸(LDV),它可能潜在地促进细胞-基质相互作用。当前,对于角蛋白的研究集中在进化生物学领域,也有材料科学领域的研究人员开始尝试将角蛋白作为支架使用。Zhao等利用角蛋白提高己内酯支架的机械性能,并发现含有交联角蛋白的支架适于支持细胞附着和增殖,其上的细胞表现出比对照组更好的细胞活力;又如,Xu等研究表明,角蛋白含有亮氨酸-天冬氨酸-缬氨酸(LDV)的细胞粘附基序以及一些能够增强神经组织再生的调节分子,对于皮肤组织工程的支架修饰而言是合适的选择。这些研究工作提示我们,角蛋白对于DPSCs可能同样具有良好的生物相容性,同时,以其为主体的支架材料亦可能是理想的控释型药物载体。本发明基于上述科学假设进行深入研究,即外源性的矿化微环境是否能对DPSCs的生长和增殖产生积极影响。Due to the presence of free sulfhydryl groups in cysteine and its low water solubility, keratin has mechanical structural plasticity and can be improved. Therefore, biological structures constructed from keratin often have enhanced mechanical strength. In addition, keratin also possesses cell-binding motifs such as leucine-aspartate-valine (LDV), which may potentially facilitate cell-matrix interactions. At present, research on keratin is focused on the field of evolutionary biology, and researchers in the field of materials science have also begun to try to use keratin as a scaffold. Zhao et al. used keratin to improve the mechanical properties of caprolactone scaffolds and found that the scaffolds containing cross-linked keratin were suitable for supporting cell attachment and proliferation, and the cells on it showed better cell viability than the control group; for another example, Xu et al. Studies have shown that keratin contains leucine-aspartate-valine (LDV) cell adhesion motifs and some regulatory molecules that can enhance nerve tissue regeneration, which is suitable for scaffold modification for skin tissue engineering. s Choice. These studies suggest that keratin may also have good biocompatibility for DPSCs, and at the same time, the scaffold material based on it may also be an ideal controlled-release drug carrier. The present invention conducts an in-depth study based on the above scientific hypothesis, that is, whether an exogenous mineralized microenvironment can positively influence the growth and proliferation of DPSCs.
本发明所采取的技术方案是:一种矿化角蛋白仿生材料的制备方法,其包括如下操作步骤:The technical scheme adopted in the present invention is: a preparation method of a mineralized keratin biomimetic material, which comprises the following operation steps:
1)纳米级角蛋白粉剂以0.1~500mg/ml的浓度加入无菌模拟体液环境中,静置矿化处理,后经室温下离心处理,弃上清并收集沉淀,进行重悬清洗、真空冷冻干燥、研磨成粉,得矿化角蛋白颗粒;1) Nano-level keratin powder is added to a sterile simulated body fluid environment at a concentration of 0.1-500 mg/ml, left to stand for mineralization, and then centrifuged at room temperature, discard the supernatant and collect the precipitate, carry out resuspension cleaning, vacuum freezing Dry and grind into powder to obtain mineralized keratin particles;
2)取步骤1)所得矿化角蛋白颗粒以0.1~500mg/ml的浓度经重悬后注入模板中,待沉淀完全后置于20~85℃烘箱中干燥1~5h,得膜状的矿化角蛋白仿生材料。2) The mineralized keratin particles obtained in step 1) were resuspended at a concentration of 0.1-500 mg/ml and then injected into the template. After the precipitation was complete, it was placed in an oven at 20-85°C and dried for 1-5 hours to obtain film-like minerals. Keratinized biomimetic material.
本发明操作过程中并未引入除了作为原材料的角蛋白之外的其它蛋白因子或者其它生物大分子,而仅是利用模拟体液为角蛋白制造出一个仿生环境,模拟自然生物矿化的过程让角蛋白实现自行矿化,使角蛋白表面发生矿化积累从而形成有利于DPSCs生长和增殖的仿生结构。In the operation process of the present invention, other protein factors or other biological macromolecules other than keratin as raw materials are not introduced, but only a bionic environment is created for keratin by simulating body fluids, and the process of simulating natural biomineralization allows keratin The protein achieves self-mineralization, and the surface of keratin is mineralized and accumulated to form a biomimetic structure that is conducive to the growth and proliferation of DPSCs.
其中,本发明中限定了步骤1)中角蛋白在模拟体液中的浓度为0.1~500mg/ml。这是因为当角蛋白浓度过低,即低于0.1mg/ml时,其矿化后的亲水性和在水中的分散性升高,会造成其矿化物不容易离心收集的操作缺陷,而当角蛋白浓度过高,即高于500mg/ml时,其容易在模拟体液中发生团聚而导致无法充分进行矿化。另外本发明限定了步骤2)中矿化角蛋白在模拟体液中的浓度亦为0.1~500mg/ml。这是因为当矿化角蛋白浓度过高或过低时,均不利于稳定地在模板中形成膜状的仿生材料。所以,本发明两个步骤中对角蛋白在模拟体液中的浓度限定是最终获得膜状仿生材料的重要工艺参数之一。经本发明进一步的实验探究,优选控制步骤1)和步骤2)中角蛋白的浓度均为50~200mg/ml。Wherein, in the present invention, the concentration of keratin in the simulated body fluid in step 1) is limited to be 0.1-500 mg/ml. This is because when the concentration of keratin is too low, that is, less than 0.1 mg/ml, the hydrophilicity and dispersibility in water after mineralization will increase, which will cause the operation defect that the mineralization is not easy to be collected by centrifugation. When the keratin concentration is too high, that is, higher than 500 mg/ml, it tends to agglomerate in simulated body fluids, resulting in insufficient mineralization. In addition, the present invention defines that the concentration of mineralized keratin in the simulated body fluid in step 2) is also 0.1-500 mg/ml. This is because when the mineralized keratin concentration is too high or too low, it is not conducive to stably form a film-like biomimetic material in the template. Therefore, limiting the concentration of keratin in the simulated body fluid in the two steps of the present invention is one of the important process parameters for finally obtaining the film-like biomimetic material. Through further experimental exploration of the present invention, it is preferable to control the concentration of keratin in both steps 1) and 2) to be 50-200 mg/ml.
值得一提的是,本发明步骤2)中所述的模板,是为矿化角蛋白膜合成提供支撑的表面和相应的直接限定的,因此在本发明的实际操作中可选用细胞培养板作为模板,亦可选用同类PVC材料所制造的具有平整结构的模板容器。It is worth mentioning that the template described in step 2) of the present invention is the surface that provides support for the synthesis of the mineralized keratin membrane and is directly defined accordingly. Therefore, in the actual operation of the present invention, a cell culture plate can be selected as the Formwork can also be made of similar PVC material with flat structure formwork container.
作为上述方案的进一步改进,步骤1)中所述静置的时间为1~6周。具体地,本发明步骤1)中所述的静置矿化处理是使角蛋白表面形貌、结构发生变化的关键操作。经大量实验研究发现,当静置矿化处理的时间到达1周时,角蛋白表面形貌、结构发生的变化亦开始随静置矿化处理时间的增加而突显;当静置矿化处理时间为6周时,角蛋白表面形貌、结构的变化最为显著,其后续所形成的角蛋白膜结构更为平整、材料间相互联结紧密,呈现出了与牙本质内部的细微结构相似的仿生结构;当静置矿化处理时间为6周以后时,角蛋白表面形貌、结构的变化逐渐趋于停止。As a further improvement of the above scheme, the standing time in step 1) is 1-6 weeks. Specifically, the static mineralization treatment described in step 1) of the present invention is a key operation to change the surface morphology and structure of keratin. After a large number of experimental studies, it was found that when the static mineralization treatment time reached 1 week, the changes in the surface morphology and structure of keratin also began to be prominent with the increase of the static mineralization treatment time; when the static mineralization treatment time increased. At 6 weeks, the change of keratin surface morphology and structure was the most significant, and the subsequent keratin membrane structure was smoother, and the materials were closely connected with each other, showing a biomimetic structure similar to the internal microstructure of dentin. ; When the mineralization treatment time was 6 weeks, the changes of keratin surface morphology and structure gradually tended to stop.
作为上述方案的进一步改进,步骤1)中所述离心处理为1000~15000rpm条件下离心1~30min。As a further improvement of the above scheme, the centrifugation in step 1) is centrifugation at 1000-15000 rpm for 1-30 min.
作为上述方案的进一步改进,步骤1)中所述矿化角蛋白颗粒的粒径为20~80nm。具体地,本发明步骤1)中所述矿化角蛋白颗粒的粒径是随着静置矿化处理时间的增加呈现逐渐下降趋势的,而当矿化角蛋白的粒径为20~80nm时,其有利于后续形成的与牙本质内部的细微结构相似的仿生膜结构。As a further improvement of the above scheme, the particle size of the mineralized keratin particles in step 1) is 20-80 nm. Specifically, the particle size of the mineralized keratin particles in step 1) of the present invention gradually decreases with the increase of the standing mineralization treatment time, and when the particle size of the mineralized keratin is 20-80 nm , which is beneficial to the subsequent formation of a biomimetic membrane structure similar to the microstructure inside the dentin.
本发明的有益效果是:本发明通过仿生合成法,诱导角蛋白自行矿化,在无需引入其它蛋白因子或者其它生物大分子的前提下构建出矿化角蛋白仿生材料。经实践表明该仿生材料可为DPSCs的生长和增殖提供一个理想的纳米矿化微环境以促进DPSCs的生长,从而为牙髓组织再生与修复的可行性提供重要的参考价值。The beneficial effects of the invention are as follows: the invention induces the self-mineralization of keratin through the biomimetic synthesis method, and constructs the biomimetic material of mineralized keratin without introducing other protein factors or other biological macromolecules. Practice shows that the biomimetic material can provide an ideal nano-mineralized microenvironment for the growth and proliferation of DPSCs to promote the growth of DPSCs, thus providing an important reference value for the feasibility of pulp tissue regeneration and repair.
附图说明Description of drawings
图1是实施例1和对比例中角蛋白颗粒的质量检测;Fig. 1 is the quality detection of keratin particles in
图2是对比例与实施例1中矿化1周和矿化6周的角蛋白颗粒的红外图谱结果;Fig. 2 is the infrared spectrum results of the keratin particles mineralized for 1 week and mineralized for 6 weeks in Comparative Example and Example 1;
图3是对比例与实施例1中矿化6周的角蛋白颗粒的XPS结果;Figure 3 is the XPS results of the keratin particles mineralized for 6 weeks in Comparative Example and Example 1;
图4是对比例与实施例1中矿化6周的角蛋白颗粒的TEM和SAED结果(左边为透射电子显微镜照片;右边为选区电子衍射图样);Figure 4 is the TEM and SAED results of the keratin particles mineralized for 6 weeks in Comparative Example and Example 1 (the left is the transmission electron microscope photo; the right is the selected area electron diffraction pattern);
图5是对比例与实施例1中矿化1周和矿化6周的角蛋白颗粒的SEM结果;Figure 5 is the SEM results of keratin particles mineralized for 1 week and mineralized for 6 weeks in Comparative Example and Example 1;
图6是实施例1和对比例中角蛋白颗粒粒径的分析结果;Fig. 6 is the analysis result of keratin particle size in
图7是对比例与实施例1中矿化1周和矿化6周的角蛋白膜材的SEM(A)和AFM(B),其中上层为空白对照组未矿化角蛋白;中层为矿化1周的矿化角蛋白;下层为矿化6周的矿化角蛋白;Fig. 7 is the SEM (A) and AFM (B) of the keratin film material mineralized for 1 week and mineralized for 6 weeks in Comparative Example and Example 1, wherein the upper layer is the unmineralized keratin of the blank control group; the middle layer is the mineralized keratin Mineralized keratin for 1 week; the lower layer for mineralized keratin for 6 weeks;
图8是对比例与实施例1中矿化1周和矿化6周的角蛋白膜材的表面粗糙度分析结果;Fig. 8 is the surface roughness analysis result of the keratin film material mineralized for 1 week and mineralized for 6 weeks in Comparative Example and Example 1;
图9是对比例与实施例1中矿化1周和矿化6周的角蛋白膜材的表面亲水性分析结果;Fig. 9 is the surface hydrophilicity analysis result of the keratin membrane material mineralized for 1 week and mineralized for 6 weeks in Comparative Example and Example 1;
图10是实施例6中不同材料表面DPSCs培养4h、24h、48h和72h后的MTT检测结果,其中“对照”是指细胞对照组,“角蛋白”是指对比例空白对照组,“矿化角蛋白”是指实施例1矿化6周的受试样品;Figure 10 is the MTT detection results of DPSCs on the surface of different materials in Example 6 after culturing 4h, 24h, 48h and 72h, wherein "control" refers to the cell control group, "keratin" refers to the blank control group of the comparative example, and "mineralization" refers to the blank control group. "Keratin" refers to the test sample mineralized for 6 weeks in Example 1;
图11是实施例6中不同材料表面DPSCs培养72h后的流式细胞周期检测,其中“对照组”是指细胞对照组,“角蛋白”是指对比例空白对照组,“矿化角蛋白”是指实施例1矿化6周的受试样品;Figure 11 is the flow cytometry detection of the DPSCs on the surface of different materials in Example 6 after culturing for 72 hours, wherein "control group" refers to the cell control group, "keratin" refers to the blank control group of the comparative example, and "mineralized keratin" Refers to the test sample mineralized for 6 weeks in Example 1;
图12是实施例6中不同材料表面DPSCs培养24和72h后的SEM检测结果,其中“角蛋白”是指对比例空白对照组,“矿化角蛋白”是指实施例1矿化6周的受试样品。Figure 12 is the SEM test results of DPSCs on the surface of different materials in Example 6 after culturing for 24 and 72 hours, wherein "keratin" refers to the blank control group of the comparative example, and "mineralized keratin" refers to the mineralized keratin in Example 1 for 6 weeks. test sample.
具体实施方式Detailed ways
下面结合实施例对本发明进行具体描述,以便于所属技术领域的人员对本发明的理解。有必要在此特别指出的是,实施例只是用于对本发明做进一步说明,不能理解为对本发明保护范围的限制,所属领域技术熟练人员,根据上述发明内容对本发明作出的非本质性的改进和调整,应仍属于本发明的保护范围。同时下述所提及的原料未详细说明的,均为市售产品;未详细提及的工艺步骤或制备方法为均为本领域技术人员所知晓的工艺步骤或制备方法。The present invention will be specifically described below with reference to the embodiments, so as to facilitate the understanding of the present invention by those skilled in the art. It is necessary to point out that the embodiments are only used to further illustrate the present invention, and should not be construed as limiting the scope of protection of the present invention. Those skilled in the art make non-essential improvements and The adjustment should still belong to the protection scope of the present invention. Meanwhile, the raw materials mentioned below are all commercially available products that are not described in detail; the process steps or preparation methods not mentioned in detail are the process steps or preparation methods known to those skilled in the art.
本发明实施例中所述的纳米级蛋白粉剂为购自广州华奇盛生物技术有限公司的小鼠源性角蛋白粉剂;所述的无菌模拟体液为购自广州华奇盛生物技术有限公司的无菌模拟体液SBF;所述的低糖αMEM培养基为购自GIBCOBRL公司的市售产品;所述的新生牛血清为购自杭州四季青生物工程材料有限公司的市售产品。The nanoscale protein powder described in the embodiment of the present invention is the mouse-derived keratin powder purchased from Guangzhou Huaqisheng Biotechnology Co., Ltd.; the sterile simulated body fluid is purchased from Guangzhou Huaqisheng Biotechnology Co., Ltd. The sterile simulated body fluid SBF; the low-glucose αMEM medium was a commercially available product from GIBCOBRL; the newborn bovine serum was a commercially available product from Hangzhou Sijiqing Bioengineering Materials Co., Ltd.
实施例1:构建矿化角蛋白仿生材料Example 1: Construction of mineralized keratin biomimetic material
一种矿化角蛋白仿生材料的制备方法,其包括如下操作步骤:A preparation method of a mineralized keratin biomimetic material, comprising the following steps:
1)取纳米级角蛋白粉剂以100mg/ml的浓度加入无菌模拟体液环境中,静置矿化处理6周,每12h轻微搅拌分散,其中每隔1周取样以作为一个试样,取样时将矿化角蛋白置于1.5ml EP管中,室温下10000rpm离心处理15min,弃上清,收集沉淀,用去离子无菌水进行重悬并清洗3次,真空冷冻干燥、研磨成粒径为50nm的粉末,分别得到矿化1~6周的矿化角蛋白颗粒并用于后续的理化表征实验;1) Get the nanoscale keratin powder and add it to the sterile simulated body fluid environment at a concentration of 100mg/ml, leave it to stand for mineralization for 6 weeks, stir and disperse slightly every 12h, and take samples every 1 week as a sample, when sampling The mineralized keratin was placed in a 1.5ml EP tube, centrifuged at 10000rpm for 15min at room temperature, the supernatant was discarded, the precipitate was collected, resuspended with deionized sterile water and washed 3 times, vacuum freeze-dried, and ground to a particle size of 50nm powder, mineralized keratin particles with mineralization for 1 to 6 weeks were obtained and used for subsequent physical and chemical characterization experiments;
2)取步骤1)所得矿化1~6周的矿化角蛋白颗粒分别以100mg/ml的浓度经重悬后注入24孔细胞培养板中,待其沉淀于24孔细胞培养板底部后,置于50℃烘箱中干燥3h,分别得矿化1~6周的膜状的矿化角蛋白仿生材料。2) Take the mineralized keratin particles obtained in step 1) that have been mineralized for 1 to 6 weeks and resuspend them at a concentration of 100 mg/ml and inject them into a 24-well cell culture plate. Placed in a 50° C. oven to dry for 3 hours, respectively, to obtain film-like mineralized keratin biomimetic materials that were mineralized for 1 to 6 weeks.
实施例2:构建矿化角蛋白仿生材料Example 2: Construction of mineralized keratin biomimetic material
一种矿化角蛋白仿生材料的制备方法,其包括如下操作步骤:A preparation method of a mineralized keratin biomimetic material, comprising the following steps:
1)取纳米级角蛋白粉剂以0.5mg/ml的浓度加入无菌模拟体液环境中,静置矿化处理6周,每12h轻微搅拌分散,待矿化结束时取样,将矿化角蛋白置于1.5ml EP管中,室温下15000rpm离心处理1min,弃上清,收集沉淀,用去离子无菌水进行重悬并清洗3次,真空冷冻干燥、研磨成粒径为20nm的粉末,得到矿化角蛋白颗粒;1) Take nano-scale keratin powder and add it to the sterile simulated body fluid environment at a concentration of 0.5mg/ml, let it stand for mineralization treatment for 6 weeks, stir and disperse slightly every 12h, take samples when the mineralization is over, and place the mineralized keratin In a 1.5ml EP tube, centrifuge at 15,000rpm for 1min at room temperature, discard the supernatant, collect the precipitate, resuspend with deionized sterile water and wash 3 times, vacuum freeze-dry, and grind into a powder with a particle size of 20nm to obtain the mineral. Keratinized particles;
2)取步骤1)所得矿化角蛋白颗粒分别以500mg/ml的浓度经重悬后注入24孔细胞培养板中,待其沉淀于24孔细胞培养板底部后,置于20℃烘箱中干燥5h,得实施例2矿化角蛋白仿生材料。2) The mineralized keratin particles obtained in step 1) were resuspended at a concentration of 500 mg/ml and injected into a 24-well cell culture plate. After they were deposited on the bottom of the 24-well cell culture plate, they were placed in a 20°C oven to dry. 5h, the mineralized keratin biomimetic material of Example 2 was obtained.
实施例3:构建矿化角蛋白仿生材料Example 3: Construction of mineralized keratin biomimetic material
一种矿化角蛋白仿生材料的制备方法,其包括如下操作步骤:A preparation method of a mineralized keratin biomimetic material, comprising the following steps:
1)取纳米级角蛋白粉剂以500mg/ml的浓度加入无菌模拟体液环境中,静置矿化处理6周,每12h轻微搅拌分散,待矿化结束时取样,将矿化角蛋白置于1.5ml EP管中,室温下1000rpm离心处理30min,弃上清,收集沉淀,用去离子无菌水进行重悬并清洗3次,真空冷冻干燥、研磨成粒径为80nm的粉末,得到矿化角蛋白颗粒;1) Take the nano-scale keratin powder and add it to the sterile simulated body fluid environment at a concentration of 500mg/ml, leave it to stand for mineralization for 6 weeks, slightly stir and disperse every 12h, take samples when the mineralization is over, and place the mineralized keratin in the environment. In a 1.5ml EP tube, centrifuge at 1000rpm for 30min at room temperature, discard the supernatant, collect the precipitate, resuspend with deionized sterile water and wash 3 times, vacuum freeze-dry, grind into a powder with a particle size of 80nm to obtain mineralization keratin particles;
2)取步骤1)所得矿化角蛋白颗粒分别以0.1mg/ml的浓度经重悬后注入24孔细胞培养板中,待其沉淀于24孔细胞培养板底部后,置于85℃烘箱中干燥1h,得实施例3矿化角蛋白仿生材料。2) The mineralized keratin particles obtained in step 1) were resuspended at a concentration of 0.1 mg/ml and injected into a 24-well cell culture plate. After they were deposited on the bottom of the 24-well cell culture plate, they were placed in an oven at 85°C. After drying for 1 hour, the mineralized keratin biomimetic material of Example 3 was obtained.
对比例:构建空白对照Comparative Example: Constructing a Blank Control
一种角蛋白膜材的制备方法,其包括如下操作步骤:A kind of preparation method of keratin film material, it comprises the following operation steps:
1)取纳米级角蛋白粉剂以100mg/ml的浓度加入无菌模拟体液环境中,置于1.5mlEP管中,室温下10000rpm离心处理15min,弃上清,收集沉淀,用去离子无菌水进行重悬并清洗3次,真空冷冻干燥、研磨成粒径为50nm的粉末,得到空白对照组角蛋白颗粒;1) Get the nanoscale keratin powder with a concentration of 100mg/ml and add it to the sterile simulated body fluid environment, place it in a 1.5ml EP tube, and centrifuge it at 10000rpm for 15min at room temperature, discard the supernatant, collect the precipitation, and carry out with deionized sterile water Resuspend and wash 3 times, vacuum freeze-dry, grind into powder with particle size of 50nm, and obtain blank control group keratin particles;
2)取步骤1)所得角蛋白颗粒以100mg/ml的浓度经重悬后注入24孔细胞培养板中,待其沉淀于24孔细胞培养板底部后,置于50℃烘箱中干燥3h,得空白对照组角蛋白膜材。2) The keratin particles obtained in step 1) were resuspended at a concentration of 100 mg/ml and injected into a 24-well cell culture plate. The blank control group was keratin film.
实施例5:矿化角蛋白仿生材料的理化表征Example 5: Physicochemical characterization of mineralized keratin biomimetic material
5.1矿化角蛋白颗粒质量检测5.1 Quality inspection of mineralized keratin particles
取对比例的空白对照组角蛋白颗粒和实施例1的矿化1~6周的矿化角蛋白颗粒分别进行质量检测,其检测结果如图1所示,矿化1~6周后,受试样品质量有所增加。具体地,矿化6周后受试样品的质量从空白对照组的0.1g增加至0.143±0.006g,质量增长率为14%,具有显著性差异,即表示经矿化处理后的角蛋白表面生成了新的物质。Take the blank control group keratin particles of the comparative example and the mineralized keratin particles of Example 1 for 1 to 6 weeks for quality testing, respectively, and the test results are shown in Figure 1. The quality of the test samples has increased. Specifically, after 6 weeks of mineralization, the mass of the test sample increased from 0.1 g in the blank control group to 0.143 ± 0.006 g, and the mass growth rate was 14%, which was a significant difference, which means that the keratin after mineralization treatment A new substance is formed on the surface.
5.2矿化角蛋白颗粒红外图谱分析5.2 Infrared analysis of mineralized keratin particles
分别取对比例的空白对照组角蛋白颗粒、实施例1中矿化1周和矿化6周的矿化角蛋白颗粒各2g,通过KBr压片法进行傅里叶红外光谱分析,控制试样与KBr混合物粒度小于2μm,以免散射光影响,其红外图谱检测结果如图2所示。结果表明,矿化作用使角蛋白的红外吸收波峰发生了变化,特别是在矿化6周后,变化更为显著。例如,根据“矿化角蛋白6w”(即矿化6周的矿化角蛋白颗粒)的检测数据,在1045.2cm-1和1174.0cm-1出现了明显的波峰,其分别是羟基磷灰石中PO4 3-的v1和v3震动特征峰,可知角蛋白经矿化后,结构发生了变化,新的化学键产生,从而引起了样品红外波谱的变化。The blank control group keratin particles of the comparative example, the mineralized keratin particles mineralized for 1 week and the mineralized keratin particles for 6 weeks in Example 1 were taken respectively, 2 g each, and the KBr tablet method was used for Fourier transform infrared spectroscopy analysis to control the sample. The particle size of the mixture with KBr is less than 2 μm, so as to avoid the influence of scattered light, and the infrared spectrum detection results are shown in Figure 2. The results showed that mineralization changed the infrared absorption peak of keratin, especially after 6 weeks of mineralization, the change was more significant. For example, according to the detection data of "
5.3矿化角蛋白颗粒XPS分析5.3 XPS analysis of mineralized keratin particles
分别取对比例的空白对照组角蛋白颗粒和实施例1中矿化6周的矿化角蛋白颗粒,采用MICROLAB MKⅡ型光电子能谱仪测量各受试样品的薄膜的XPS能谱,靶分别为Ca和P、电子枪空间分辨率为50nm、电压10kV。其XPS检测结果如图3所示。检测结果显示实施例1中受试样品矿化6周后,XPS结合能347eV和133eV处出现明显的特征峰,表明矿化后的角蛋白表面富集了更多的钙离子和磷离子,其结合上述傅里叶红外图谱分析结果可知,矿化后的角蛋白表面新形成的物质可能是羟基磷灰石类似物。Take the blank control group keratin particles of the comparative example and the mineralized keratin particles in Example 1 for 6 weeks respectively, and use a MICROLAB MK II photoelectron spectrometer to measure the XPS energy spectrum of the film of each test sample. For Ca and P, the spatial resolution of the electron gun is 50 nm, and the voltage is 10 kV. The XPS test results are shown in Figure 3. The test results show that after 6 weeks of mineralization of the tested sample in Example 1, obvious characteristic peaks appear at the XPS binding energies of 347eV and 133eV, indicating that the mineralized keratin surface is enriched with more calcium ions and phosphorus ions, Combined with the above analysis results of Fourier transform infrared spectrum, it can be known that the newly formed substances on the surface of keratin after mineralization may be analogs of hydroxyapatite.
5.4矿化角蛋白颗粒TEM和SAED分析5.4 TEM and SAED analysis of mineralized keratin particles
分别取对比例的空白对照组与实施例1中矿化6周的矿化角蛋白颗粒对其进行TEM和SAED分析。如图4(左)所示,矿化6周使角蛋白的结构发生了改变,具体地矿化作用增加了角蛋白的颗粒性,角蛋白电子密度降低、边界变得明显、颗粒间彼此分离。如图4(右)所示,空白对照组未经矿化的角蛋白SAED并不呈现明显的晶体规则、图像中亮斑之间距离不一、各点呈分散分布,但基本围绕图样中心排列于同心圆上,即其为电子束经过角蛋白的α螺旋后所衍射出的图样;而经过矿化6周的作用,受试样品的SAED图谱上出现了规则的四边形结构、各亮斑之间排列均一、呈规则四边形,由此推断得矿化作用可使角蛋白表面形貌发生变化,且出现四面体的晶体结构。The blank control group of the comparative example and the mineralized keratin particles mineralized for 6 weeks in Example 1 were respectively taken for TEM and SAED analysis. As shown in Figure 4 (left), 6 weeks of mineralization changed the structure of keratin. Specifically, the mineralization increased the granularity of keratin, the electron density of keratin decreased, the boundary became obvious, and the particles were separated from each other. . As shown in Figure 4 (right), the unmineralized keratin SAED in the blank control group did not show obvious crystal regularity, the distances between the bright spots in the image were different, and the points were scattered, but basically arranged around the center of the pattern On the concentric circles, it is the pattern diffracted by the electron beam after passing through the α-helix of keratin; and after 6 weeks of mineralization, regular quadrilateral structures and bright spots appear on the SAED spectrum of the test sample. They are arranged uniformly and are regular quadrilaterals. From this, it is inferred that mineralization can change the surface morphology of keratin, and the crystal structure of tetrahedron appears.
5.5矿化角蛋白颗粒SEM分析5.5 SEM analysis of mineralized keratin particles
分别取对比例的空白对照组角蛋白颗粒和实施例1中矿化6周的矿化角蛋白颗粒,将各受试样品自然风干后黏贴固定于样品台上并做喷金处理,置于扫描电镜样品室内,抽真空,进行电镜观察。其观察结果如图5所示(左图空白对照组、中图矿化1周、右图为矿化6周),空白对照组未经矿化的角蛋白相互联结缠绕,形成块状结构,边界并不明显,而经1周和6周矿化后,角蛋白出现明显的颗粒状结构,颗粒均匀,颗粒间相互联结形成的片状结构明显减少,颗粒间呈现明显的相互独立性,其分析结果与TEM检测结果相对应。The blank control group keratin granules of the comparative example and the mineralized keratin granules in Example 1 were respectively taken for 6 weeks, and the tested samples were naturally air-dried and then pasted and fixed on the sample table and sprayed with gold. In the scanning electron microscope sample chamber, vacuumize and observe the electron microscope. The observation results are shown in Figure 5 (blank control group in the left picture, mineralized for 1 week in the middle picture, and mineralized for 6 weeks in the right picture). The boundary is not obvious, but after 1 week and 6 weeks of mineralization, the keratin has obvious granular structure, and the particles are uniform. The analysis results corresponded to the TEM detection results.
5.6矿化角蛋白颗粒粒径5.6 Mineralized keratin particle size
取对比例的空白对照组角蛋白颗粒和实施例1的矿化1~6周的矿化角蛋白颗粒分别进行粒径检测,其检测结果如图6所示,发现角蛋白的粒径随着矿化时间的增加呈现逐渐下降的趋势,具体地对比例的空白对照组角蛋白颗粒粒径为100nm,矿化3周后颗粒粒径下降至50nm,下降了50%,而随着矿化时间的进一步延长,矿化角蛋白颗粒粒径在6周后可达30nm,而1~6周的检测结果较对比例的空白对照组而言P<0.01,具有统计学差异。Take the keratin particles of the blank control group of the comparative example and the mineralized keratin particles of Example 1 for 1 to 6 weeks for particle size detection respectively. The detection results are shown in Figure 6. It is found that the particle size of keratin increases with The increase of mineralization time showed a gradual downward trend. Specifically, the particle size of keratin particles in the blank control group of the comparative example was 100 nm. After 3 weeks of mineralization, the particle size decreased to 50 nm, a decrease of 50%. The particle size of mineralized keratin particles can reach 30 nm after 6 weeks, and the detection results of 1 to 6 weeks are compared with the blank control group of the comparative example, P<0.01, which is statistically different.
5.7矿化角蛋白膜材表面形貌5.7 Surface morphology of mineralized keratin film
取对比例的空白对照组角蛋白颗粒、实施例1中矿化1周和矿化6周的矿化角蛋白仿生材料分别通过SEM和AFM进行表面形貌观察,如图7所示,矿化处理时长不同,对角蛋白成膜的效果将产生影响,具体地空白对照组未矿化的角蛋白所形成的膜结构存在更多的孔洞结构,表面不平整,相比之下矿化处理6周后的矿化角蛋白所形成的膜结构更为平整,材料间相互联结紧密,且其所呈现的结构与牙本质内部的细微结构相似,这表面本发明的矿化角蛋白仿生材料可能模拟牙齿内部的结构,未后续DPSCs的生长和分化提供理想的微环境。5.8矿化角蛋白膜材表面粗糙度Take the blank control group keratin particles of the comparative example, and the mineralized keratin biomimetic materials in Example 1 that were mineralized for 1 week and mineralized for 6 weeks to observe the surface morphology by SEM and AFM, respectively. As shown in Figure 7, the mineralization Different treatment time will have an impact on the effect of keratin film formation. Specifically, the film structure formed by unmineralized keratin in the blank control group has more pore structures and the surface is uneven. In contrast, the
取对比例的空白对照组角蛋白颗粒、实施例1中矿化1周和矿化6周的矿化角蛋白仿生材料分别进行粗糙度分析。具体地的操作方法为取每块受试样品上表面10μm×10μm大小的区域,分为200层进行扫描,每一层分为200个扫描点,故每个区域共分为4×104个扫描点。仪器扫描所得数据通过NanoScope Analysis 1.5(Bruker,Germany)和OriginPro 9(OriginLab,USA)进行处理,得到可视化三维图形和二维图形。继而,定义了角蛋白膜材每一层平均粗糙度Ra公式如下:公式中,Zn表示每个扫描点的高度,代表该层平均高度。计算出每一层的Ra后,再计算出同一角蛋白膜材的200个片层的平均Ra值,以此代表其粗糙度。如图8所示,随着矿化时间的延长,所形成的角蛋白膜材的粗糙度逐渐下降,实施例两个受试样品的粗糙度较空白对照组的下降了50%,这与矿化角蛋白颗粒的SEM结果相对应,表明本发明的矿化角蛋白仿生材料表面的空隙减少、表面变得平整。The keratin particles of the blank control group of the comparative example and the mineralized keratin biomimetic materials of Example 1 that were mineralized for 1 week and mineralized for 6 weeks were respectively used for roughness analysis. The specific operation method is to take a 10μm×10μm area on the upper surface of each test sample, divide it into 200 layers for scanning, and each layer is divided into 200 scanning points, so each area is divided into 4×10 4 scan points. The data scanned by the instrument were processed by NanoScope Analysis 1.5 (Bruker, Germany) and OriginPro 9 (OriginLab, USA) to obtain visualized 3D and 2D graphics. Then, the formula of the average roughness Ra of each layer of the keratin film is defined as follows: In the formula, Zn represents the height of each scanning point, Represents the average height of the layer. After calculating the Ra of each layer, calculate the average Ra value of 200 layers of the same keratin film to represent its roughness. As shown in Figure 8, with the extension of the mineralization time, the roughness of the formed keratin film gradually decreased, and the roughness of the two test samples in Example decreased by 50% compared with that of the blank control group, which was consistent with that of the blank control group. The SEM results of the mineralized keratin particles correspond to each other, indicating that the voids on the surface of the mineralized keratin biomimetic material of the present invention are reduced and the surface becomes smooth.
5.9矿化角蛋白膜材亲水性5.9 Hydrophilicity of mineralized keratin film
取对比例的空白对照组角蛋白颗粒、实施例1中矿化1周和矿化6周的矿化角蛋白仿生材料分别进行表面亲水性分析,如图9所示,矿化6周的矿化角蛋白所形成的膜材具有更高的亲水性,表现为表面接触角数值的减少,且较空白对照组和实施例1中矿化1周的受试样品而言具有显著性差异,表面本发明的矿化角蛋白仿生材料的生物相容性更好,更有利于DPSCs在其上的生长。Take the blank control group keratin particles of the comparative example, and the mineralized keratin biomimetic materials mineralized for 1 week and mineralized for 6 weeks in Example 1 for surface hydrophilicity analysis respectively, as shown in FIG. The film formed by mineralized keratin has higher hydrophilicity, which is manifested as a decrease in the surface contact angle value, which is significantly higher than that of the blank control group and the test sample mineralized for 1 week in Example 1. On the surface, the mineralized keratin biomimetic material of the present invention has better biocompatibility and is more favorable for the growth of DPSCs thereon.
实施例6:细胞培养Example 6: Cell Culture
取由赛百慷(上海)生物技术股份有限公司提供的大鼠牙髓干细胞(DPSCs),分装到24孔或96孔细胞培养板中,再分别加入对比例空白对照组的角蛋白膜材和实施例1中矿化6周的的矿化角蛋白仿生材料,保证各孔加入的角蛋白总体质量一致,并将未加入角蛋白膜材或矿化角蛋白仿生材料的纯大鼠牙髓干细胞作为细胞对照组。细胞在培养瓶中融合培养至80%后,以1×104~3×104/孔的密度接种至细胞培养板上,培养72h,以进行后续的MTT检测、流式细胞检测和扫描电镜观察。其它细胞培养条件为:含10%新生牛血清的低糖αMEM培养基,37℃,5.0%CO2。Rat dental pulp stem cells (DPSCs) provided by Saibaikang (Shanghai) Biotechnology Co., Ltd. were taken and dispensed into 24-well or 96-well cell culture plates, and the keratin membrane materials of the blank control group were added respectively. With the mineralized keratin biomimetic material mineralized for 6 weeks in Example 1, the overall quality of the keratin added in each hole is guaranteed to be consistent, and the pure rat dental pulp without keratin membrane material or mineralized keratin biomimetic material is used. Stem cells served as a cell control group. After the cells were confluent and cultured to 80% in the culture flask, they were seeded on the cell culture plate at a density of 1×10 4 to 3×10 4 /well, and cultured for 72 hours for subsequent MTT detection, flow cytometry and scanning electron microscopy. Observed. Other cell culture conditions were: low glucose αMEM medium containing 10% newborn calf serum, 37°C, 5.0% CO 2 .
6.1MTT检测6.1MTT detection
取细胞培养后的细胞液弃培养液,加入浓度为5mg/ml的MTT,比例为1:10,37℃孵育4h。弃上清,加入DMSO 100μL,充分振荡,溶解结晶,酶标仪检测490nm吸光值,进行MTT检测,其检测结果如图10所示。根据MTT检测结果可知,DPSCs显示出了明显不同的生长情况,实施例1中矿化6周的受试样品的结果明显优于对比例空白对照组和细胞对照组的受试样品。从数据上来看,在培养24h后,矿化6周的受试样品的OD值分别约为细胞对照组的3倍和空白对照组的2倍,而这一倍数关系在细胞培养48h和72h小时后,进一步被扩大。培养72h后,矿化6周的受试样品的OD值为~3.0,而细胞对照组的OD值<1.0,即表面本发明的矿化角蛋白仿生材料更适宜DPSCs的生长并可显著地促进该细胞的增殖。Discard the culture medium from the cell liquid after cell culture, add MTT with a concentration of 5 mg/ml, the ratio is 1:10, and incubate at 37 °C for 4 h. Discard the supernatant, add 100 μL of DMSO, shake sufficiently, dissolve the crystals, detect the absorbance at 490 nm with a microplate reader, and perform MTT detection. The detection results are shown in Figure 10 . According to the MTT detection results, DPSCs showed significantly different growth conditions, and the results of the test samples mineralized for 6 weeks in Example 1 were significantly better than those of the blank control group and the cell control group in the comparative example. From the data point of view, after culturing for 24h, the OD value of the test sample after 6 weeks of mineralization was about 3 times that of the cell control group and 2 times that of the blank control group, respectively, and this fold relationship was observed after 48h and 72h of cell culture. Hours later, it was further expanded. After culturing for 72 hours, the OD value of the test sample that had been mineralized for 6 weeks was ~3.0, while the OD value of the cell control group was less than 1.0, that is, the mineralized keratin biomimetic material of the present invention was more suitable for the growth of DPSCs and could significantly enhance the growth of DPSCs. promote the proliferation of the cells.
6.2流式细胞检测6.2 Flow Cytometry
细胞培养72h后收集细胞,过流式细胞仪进行细胞计数。同时,采用流式细胞术检测细胞周期,以表征细胞的增殖情况。其检测结果如图11所示,实施例1中矿化6周的受试样品上的细胞较高比例的通过了G1周期检验点,进入了S、G2或M期,处于G1/G0期的细胞比例较细胞对照组下调了21%,同时实施例1中矿化6周的受试样品上的S期细胞比例较高,为26.71%,且较其余两组有显著性差异,而对比例空白对照组G2/M期细胞比例较高,为22.23%Cells were collected after 72 h of cell culture, and counted by flow cytometry. At the same time, the cell cycle was detected by flow cytometry to characterize the proliferation of cells. The test results are shown in Figure 11. In Example 1, a relatively high proportion of cells on the test sample that had been mineralized for 6 weeks passed the G1 cycle checkpoint, entered the S, G2 or M phase, and were in the G1/G0 phase. Compared with the cell control group, the proportion of cells in the S-phase decreased by 21%, while the proportion of S-phase cells in the test sample that had been mineralized for 6 weeks in Example 1 was higher, at 26.71%, and there was a significant difference compared with the other two groups, while The proportion of cells in G2/M phase in the blank control group was higher, which was 22.23%
6.3扫描电镜观察6.3 Scanning electron microscope observation
根据图12所示可知,细胞培养引起了角蛋白膜材表面形貌的变化。对比例空白对照组的角蛋白膜材表面起伏较多,其局部结构多呈现球状或颗粒状结构,颗粒表面光滑,无多余结构,而实施例1中矿化6周的受试样品中,其仿生材料表面整体平整,同时出现管状结构,由此推断出管状结构应为DPSCs上生长的可用于附着材料的黏连蛋白或胶原蛋白。As shown in FIG. 12 , it can be seen that the surface morphology of the keratin membrane material was changed by the cell culture. Comparative example The surface of the keratin film in the blank control group has many undulations, and its local structure mostly presents a spherical or granular structure, and the particle surface is smooth and has no extra structure. The surface of the biomimetic material was flat as a whole, and a tubular structure appeared at the same time. It was inferred that the tubular structure should be the cohesin or collagen grown on the DPSCs that could be used to attach the material.
综上,本发明的矿化角蛋白仿生材料对于DPSCs有较好的生物相容性,能够为细胞生长和增殖提供良好的环境,以促进细胞的生长。因此,具有进一步开发成可用于牙髓组织修复的生物材料的潜能。In conclusion, the mineralized keratin biomimetic material of the present invention has good biocompatibility for DPSCs, and can provide a good environment for cell growth and proliferation, so as to promote cell growth. Therefore, it has the potential to be further developed into biomaterials that can be used for pulp tissue repair.
上述实施例为本发明的优选实施例,凡与本发明类似的工艺及所作的等效变化,均应属于本发明的保护范畴。The above-mentioned embodiments are preferred embodiments of the present invention, and all processes similar to those of the present invention and equivalent changes made shall belong to the protection scope of the present invention.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911131307.4A CN110787322B (en) | 2019-11-19 | 2019-11-19 | Mineralized keratin bionic material and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911131307.4A CN110787322B (en) | 2019-11-19 | 2019-11-19 | Mineralized keratin bionic material and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110787322A true CN110787322A (en) | 2020-02-14 |
CN110787322B CN110787322B (en) | 2021-11-30 |
Family
ID=69445318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911131307.4A Active CN110787322B (en) | 2019-11-19 | 2019-11-19 | Mineralized keratin bionic material and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110787322B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112263710A (en) * | 2020-09-23 | 2021-01-26 | 同济大学 | A bioceramic scaffold with both anti-inflammatory and bone-cartilage repair functions and its preparation method and application |
CN113304322A (en) * | 2021-06-11 | 2021-08-27 | 北京中瑞联合生物科技有限公司 | Keratin material and cell compound for cartilage repair and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1127140A (en) * | 1994-07-22 | 1996-07-24 | 莱雅公司 | Cosmetic and skin-usefull composition containing water from hot spring, mineral water and agent against acne and oldening |
EP1277482A2 (en) * | 1999-03-19 | 2003-01-22 | The Regents of The University of Michigan | Mineralization and cellular patterning on biomaterial surfaces |
EP1551471A1 (en) * | 2002-07-25 | 2005-07-13 | Keraplast Technologies Ltd. | Bioactive coating for medical devices comprising keratin |
CN105251050A (en) * | 2015-10-22 | 2016-01-20 | 上海纳米技术及应用国家工程研究中心有限公司 | Preparation method of calcium phosphate-silk fibroin-zinc oxide composite coating |
CN105597155A (en) * | 2015-12-30 | 2016-05-25 | 湖北赛罗生物材料有限责任公司 | Method for preparing hydroxyapatite-natural macromolecular nano compound with one-pot method |
CN106754665A (en) * | 2016-12-28 | 2017-05-31 | 浙江大学 | The micron-nano topological structure of Derived from Mesenchymal Stem Cells is promoted to prepare and differentiation method |
CN107982551A (en) * | 2017-11-21 | 2018-05-04 | 东华大学 | The method that biomineralization method prepares gadolinium oxide base magnetic resonance contrast agent |
-
2019
- 2019-11-19 CN CN201911131307.4A patent/CN110787322B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1127140A (en) * | 1994-07-22 | 1996-07-24 | 莱雅公司 | Cosmetic and skin-usefull composition containing water from hot spring, mineral water and agent against acne and oldening |
EP1277482A2 (en) * | 1999-03-19 | 2003-01-22 | The Regents of The University of Michigan | Mineralization and cellular patterning on biomaterial surfaces |
EP1551471A1 (en) * | 2002-07-25 | 2005-07-13 | Keraplast Technologies Ltd. | Bioactive coating for medical devices comprising keratin |
CN105251050A (en) * | 2015-10-22 | 2016-01-20 | 上海纳米技术及应用国家工程研究中心有限公司 | Preparation method of calcium phosphate-silk fibroin-zinc oxide composite coating |
CN105597155A (en) * | 2015-12-30 | 2016-05-25 | 湖北赛罗生物材料有限责任公司 | Method for preparing hydroxyapatite-natural macromolecular nano compound with one-pot method |
CN106754665A (en) * | 2016-12-28 | 2017-05-31 | 浙江大学 | The micron-nano topological structure of Derived from Mesenchymal Stem Cells is promoted to prepare and differentiation method |
CN107982551A (en) * | 2017-11-21 | 2018-05-04 | 东华大学 | The method that biomineralization method prepares gadolinium oxide base magnetic resonance contrast agent |
Non-Patent Citations (4)
Title |
---|
CHUNXIA GAO等: "Preparation and Characterization of Biomimetic Hydroxyapatite Nanocrystals by Using Partially Hydrolyzed Keratin as Template Agent", 《NANOMATERIALS》 * |
RYO NAKATA等: "Preparation of keratin hydrogel/hydroxyapatite composite and its evaluation as a controlled drug release carrier", 《MATERIALS SCIENCE AND ENGINEERING C》 * |
WU-YA CHEN等: "M-keratin nano-materials create a mineralized micro-circumstance to promote proliferation and differentiation of DPSCs", 《JOURNAL OF MATERIALS SCIENCE: MATERIALS IN MEDICINE》 * |
沈彤: "丝素蛋白调控磷酸钙生物矿化的研究进展 ", 《丝绸》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112263710A (en) * | 2020-09-23 | 2021-01-26 | 同济大学 | A bioceramic scaffold with both anti-inflammatory and bone-cartilage repair functions and its preparation method and application |
CN113304322A (en) * | 2021-06-11 | 2021-08-27 | 北京中瑞联合生物科技有限公司 | Keratin material and cell compound for cartilage repair and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN110787322B (en) | 2021-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhao et al. | Magnetic bioinspired micro/nanostructured composite scaffold for bone regeneration | |
Miranda et al. | Three-dimensional culture of rat BMMSCs in a porous chitosan-gelatin scaffold: A promising association for bone tissue engineering in oral reconstruction | |
Harada et al. | Differential effects of different forms of hydroxyapatite and hydroxyapatite/tricalcium phosphate particulates on human monocyte/macrophages in vitro | |
Gao et al. | Characterization and osteoblast-like cell compatibility of porous scaffolds: bovine hydroxyapatite and novel hydroxyapatite artificial bone | |
He et al. | Rapid mineralization of porous gelatin scaffolds by electrodeposition for bone tissue engineering | |
CN101693126B (en) | Preparation method of poly (lactic acid-glycolic acid)/hydroxyapatite nanofiber compound bracket for bone repair | |
Li et al. | Controllable synthesis of biomimetic hydroxyapatite nanorods with high osteogenic bioactivity | |
Nie et al. | Nano-hydroxyapatite mineralized silk fibroin porous scaffold for tooth extraction site preservation | |
Gautam et al. | Surface modification of PCL-gelatin-chitosan electrospun scaffold by nano-hydroxyapatite for bone tissue engineering | |
Sumathra et al. | A phosphorylated chitosan armed hydroxyapatite nanocomposite for advancing activity on osteoblast and osteosarcoma cells | |
Ye et al. | Rapid biomimetic mineralization of collagen fibrils and combining with human umbilical cord mesenchymal stem cells for bone defects healing | |
Wang et al. | A 3D graphene coated bioglass scaffold for bone defect therapy based on the molecular targeting approach | |
CN103816574B (en) | The preparation method that a kind of surface has the medical titanium alloy of antibiotic property nanostructured | |
Zou et al. | A biocompatible silicon nitride dental implant material prepared by digital light processing technology | |
CN108992708A (en) | Modified bone meal in surface and preparation method thereof | |
CN111849013A (en) | A nano-hydroxyapatite-silk fibroin mineralized scaffold and its preparation method and use | |
CN110787322A (en) | A kind of mineralized keratin biomimetic material and preparation method thereof | |
CN102008752A (en) | Porous biphasic calcium phosphate biological scaffold with nano hydroxyapatite coating and preparation method thereof | |
Wei et al. | Biodegradable silk fibroin scaffold doped with mineralized collagen induces bone regeneration in rat cranial defects | |
Liu et al. | Three-dimensional porous reduced graphene oxide/hydroxyapatite membrane for guided bone regeneration | |
Liu et al. | In situ growth of nano-hydroxyapatite on multilayered Ti3C2Tx MXene as a drug carrier with superior-performance | |
Chen et al. | ln vitro assessment of immunomodulatory and osteogenic properties in 3D-printed hydroxyapatite/barium titanate piezoelectric ceramic scaffolds | |
CN102100927B (en) | Porous hydroxy calcium phosphate nanometer particle-modified titanium-based titanate nanowire biologic support material and preparation method thereof | |
CN108744047A (en) | A kind of preparation method of titanium nanometer/fibroin albumen/hydroxyapatite composite medical titanium coating | |
CN112126926B (en) | Preparation method of titanium surface-modified nanostructures simultaneously loaded with bioactive zinc ions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 528000 No. 18, Jiangwan Road, Chancheng District, Guangdong, Foshan Patentee after: Foshan University Country or region after: China Address before: 528000 No. 18, Jiangwan Road, Chancheng District, Guangdong, Foshan Patentee before: FOSHAN University Country or region before: China |
|
CP03 | Change of name, title or address |